Detalhe da pesquisa
1.
Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
BMC Musculoskelet Disord
; 18(1): 310, 2017 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28724365